tert-Butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indoline-1-carboxylate, 98%, 250mg

5-Methylquinoxaline, 97.0%, 25g

9,10-Bis(3,5-dihydroxyphenyl)anthracene>98.0%(HPLC)1g

2-(4-(Tert-butyl)phenyl)propanoic acid, 95%, 500mg

9,10-Bis(diethylphosphonomethyl)anthracene>98.0%(GC)1g

4'-Trifluoromethylbiphenyl-4-carboxylic acid, 95.0%, 250mg

(5-Bromo-2-fluorophenyl)(cyclopropyl)methanamine, 97%, 250mg

Tripropylene glycol monobutyl ether, min 95%, for synthesis, 2.5 l, plastic packaging.

Tris(hydroxymethyl)aminomethane Hydrochloride>98.0%(N)500g

(S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 95.0%, 50mg

(E)-Ethyl 4-Nitrocinnamate>98.0%(GC)5g

Methacrolein (stabilized with HQ)>90.0%(GC)100mL

1-Bromo-3-cyclopropylbenzene, 97.0%, 1g